drugset / Trial / NCT00311883
Hydroxychloroquine in Cystic Fibrosis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Study levels of inflammatory mediators in induced sputum of patients with cystic fibrosis before and after a 4 week course of oral hydroxychloroquine.
Timeline
- Start
- 2006-03
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxychloroquine | Small molecule | 200 mg | Oral |